Haleos Labs Ltd
Fri 12/06/2026,15:40:12 | NSE : HALEOSLABS
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1399.60
Previous Close
₹ 1403.10
Volume
524
Mkt Cap ( Rs. Cr)
₹425.13
High
₹ 1429.90
Low
₹ 1380.20
52 Week High
₹ 1774.00
52 Week Low
₹ 1067.00
Book Value Per Share
₹ 706.34
Dividend Yield
0.11
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Haleos Labs Ltd
Your Vote -
Buy
38.64%
Hold
11.36%
Sell
50.00%
38.64%
44 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
1406.20
10
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
10
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Haleos Labs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Haleos Labs - Updates
-
Haleos Labs - Copy of Newspaper Publication
-
Haleos Labs - Sub-Committees Of Board (Reconstitution)
-
Haleos Labs - Newspaper Publication (Financial Results)
-
Haleos Labs - Financial Results (Q4/F26)
-
Haleos Labs - Announcement under Regulation 30 (LODR)-Change in Management
-
Haleos Labs - Auditors Appointment
-
Haleos Labs - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Haleos Labs Q4 net profit down 16.79% at Rs 2.23 cr
-
Haleos Labs - Board Meeting Outcome for Meeting Held On May 26, 2026
-
Haleos Labs - Updates
-
Haleos Labs - Saksham Niveshak
-
Haleos Labs - Board Meeting Intimation for 97Th Board Meeting (29.05.2026)
-
Haleos Labs - Credit Rating
-
Haleos Labs - Announcement under Regulation 30 (LODR)-Credit Rating
-
Haleos Labs - Shareholders meeting
-
Haleos Labs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Haleos Labs - Updates
-
Haleos Labs - Encumbrance (Annual Disclosure)
-
Haleos Labs - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Haleos Labs - Updates
-
Haleos Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Haleos Labs - Annual Confirmation (Reclassification)
-
Haleos Labs - Copy of Newspaper Publication
-
Haleos Labs - Newspaper Publication (Postal Ballot)
-
Haleos Labs - Updates
-
Haleos Labs - Shareholders meeting
-
Haleos Labs - New Email ID & Website
-
Haleos Labs - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Haleos Labs - Updates
-
Haleos Labs - Events Calendar (Postal Ballot)
-
Haleos Labs - Trading Window
-
SMS Pharma receives non-exclusive license to manufacture & supply Molnupiravir
Key fundamentals
Evaluate the intrinsic value of Haleos Labs Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 307.6849 | 276.348 | 264.957 | 249.1726 | 210.9553 |
| Liabilities | 307.6849 | 276.348 | 264.957 | 249.1726 | 210.9553 |
| Equity | 3.0233 | 3.0233 | 3.0233 | 3.0233 | 3.0233 |
| Gross Profit | 40.4682 | 44.2317 | 34.4313 | 26.4065 | 31.3647 |
| Net Profit | 17.7768 | 21.3708 | 13.0654 | 13.2176 | 25.3813 |
| Cash From Operating Activities | 38.4304 | 28.0325 | 14.7514 | 4.5753 | -14.6554 |
| NPM(%) | 5.9 | 6.41 | 4.35 | 4.19 | 7.34 |
| Revenue | 300.9896 | 333.371 | 300.0016 | 315.2418 | 345.6281 |
| Expenses | 260.5214 | 289.1393 | 265.5703 | 288.8353 | 314.2634 |
| ROE(%) | 8.32 | 10 | 6.11 | 6.18 | 11.88 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 1.5 | 15 | 0.11 | 1581.3 | |
| 1.5 | 15 | 0.11 | 1373.4 | |
| 23 Sep 2024 | 1.5 | 15 | 0.11 | 696.3 |
| 22 Sep 2022 | 1.5 | 15 | 0.11 | 637.6 |
| 20 Sep 2021 | 1.5 | 15 | 0.11 | 659.8 |
| 19 Sep 2019 | 1.5 | 15 | 0.11 | 483.4 |
Peers
Other companies within the same industry or sector that are comparable to Haleos Labs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 725.60 | 4.43 | 0.00 | 770.81 | -26.19 | 0.69 |
| Lotus Eye Hospital and Institute Ltd | 135.10 | 0.65 | 4503.33 | 2808.75 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.14 | -0.56 | 23.03 | 17620.21 | 15.96 | 0.00 |
| Astec Lifesciences Ltd | 769.60 | -0.25 | 0.00 | 2648.71 | -363.14 | 0.00 |
Company Info
SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.
SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.
Read More
Parent Organisation
Haleos Labs Ltd.
Founded
31/05/2006
Managing Director
Mr.TVVSN Murthy
NSE Symbol
HALEOSLABSEQ
FAQ
The current price of Haleos Labs Ltd is ₹ 1406.20.
The 52-week high for Haleos Labs Ltd is ₹ 1429.90 and the 52-week low is ₹ 1380.20.
The market capitalization of Haleos Labs Ltd is currently ₹ 425.13. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Haleos Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Haleos Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Haleos Labs Ltd shares.
The CEO of Haleos Labs Ltd is Mr.TVVSN Murthy, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
